Research theme for competitive and other funds (1)：
2014 - 2017 The association between long-term prognoses and FDG-PET parameters of biliary cancer -Comparison to the expression of KRAS,BRAF,EGFR,Ki-67,VEGFA and HIF-1-
Papers (41)：
Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi, et al. Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast cancer. 2024. Online ahead of print
T. Koyama, N. Kiyota, S. Boku, Y. Imamura, N. Shibata, H. Satake, K. Tanaka, H. Hayashi, T. Onoe, Y. Asada, et al. A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody. ESMO Open. 2024. 9. 6. 103476-103476
Sohei Satoi, Tomohisa Yamamoto, Daisuke Hashimoto, So Yamaki, Yuki Matsui, Tsukasa Ikeura, Shogen Boku, Nobuhiro Shibata, Denys Tsybulskyi, Mitsugu Sekimoto. Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study. Journal of gastrointestinal oncology. 2023. 14. 6. 2587-2599
Naoki Niikura, Takashi Yamanaka, Hironori Nomura, Kazuhiro Shiraishi, Hiroki Kusama, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Shosuke Kita, et al. Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM). NPJ breast cancer. 2023. 9. 1. 82-82
Nobuhiro Shibata, Tetsuhiro Yoshinami, Kentaro Tamaki, Tomoyuki Nukada, Shinji Ohno. Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer. Breast Cancer Research and Treatment. 2023. 201. 2. 265-273
Efficacy of olanzapine in the prophylaxis of delayed chemotherapy-induced nausea and vomitingients receiving dose-dense AC with a steroid-sparing regimen: A single-center pilot study
(ESMO Asia Congress 2023 2023)
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: A multicenter retrospective study (ROSET-BM study)
(San Antonio Breast Cancer Symposium 2022 2022)
2024/07 - 現在 Kansai Medical University Hospital Department of Clinical Oncology
2019/08 - 2024/06 関西医科大学附属病院 がんセンター 診療講師
2018/10 - 2019/07 University of Miyazaki Faculty of Madicine College Hospital Assistant Professor
2012/10/01 - 2018/09/30 University of Miyazaki Faculty of Madicine College Hospital Cancer diagnosis and treatment part Department of Medical Oncology Assistant Professor
Committee career (2)：
2024/01 - 現在 日本乳癌学会 教育・研修委員会 教育セミナー企画WG
2018/04/01 - 現在 日本臨床腫瘍学会 がん免疫療法エキスパートセミナーWG
Awards (1)：
2020/01 - 宮崎大学医学部附属病院治験貢献賞
Association Membership(s) (8)：
European Society for Medical Oncology(ESMO)
, Japan Surgical Society
, American Society of Clinical Oncology (ASCO)
, European Society for Medical Oncology (ESMO)
, The Japan Society of Clinical Oncology
, The Japanese Society of Gastroenterology
, Japanese Breast Cancer Society
, Japanese Society of Medical Oncology
